BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6323901)

  • 1. Are dihydropyridine binding sites voltage sensitive calcium channels?
    Miller RJ; Freedman SB
    Life Sci; 1984 Mar; 34(13):1205-21. PubMed ID: 6323901
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels.
    Schwartz LM; McCleskey EW; Almers W
    Nature; 1985 Apr 25-May 1; 314(6013):747-51. PubMed ID: 2581141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and pharmacological approaches to the definition and quantitation of calcium channels.
    Gengo PJ; Luchowski E; Rampe DE; Rutledge A; Triggle AM; Triggle DJ; Janis RA
    Cold Spring Harb Symp Quant Biol; 1983; 48 Pt 1():279-85. PubMed ID: 6327161
    [No Abstract]   [Full Text] [Related]  

  • 8. [3H]nitrendipine labelling of the Ca2+ channel in skeletal muscle.
    Fosset M; Jaimovich E; Delpont E; Lazdunski M
    Eur J Pharmacol; 1982 Dec; 86(1):141-2. PubMed ID: 6297924
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
    Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
    J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranes.
    Rampe D; Luchowski E; Rutledge A; Janis RA; Triggle DJ
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1452-60. PubMed ID: 2444320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular properties of the slow inward calcium channel. Molecular weight determinations by radiation inactivation and covalent affinity labeling.
    Venter JC; Fraser CM; Schaber JS; Jung CY; Bolger G; Triggle DJ
    J Biol Chem; 1983 Aug; 258(15):9344-8. PubMed ID: 6308002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible dihydropyridine isothiocyanate binding to brain calcium channels.
    Greenberg DA; Cooper EC; Carpenter CL
    J Neurochem; 1985 Jan; 44(1):319-21. PubMed ID: 2578060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL; Schwartz A
    Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
    Schoemaker H; Boles RG; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
    [No Abstract]   [Full Text] [Related]  

  • 18. High affinity binding of a calcium channel antagonist to smooth and cardiac muscle.
    Bolger GT; Gengo PJ; Luchowski EM; Siegel H; Triggle DJ; Janis RA
    Biochem Biophys Res Commun; 1982 Feb; 104(4):1604-9. PubMed ID: 7073757
    [No Abstract]   [Full Text] [Related]  

  • 19. Ontogenic appearance of Ca2+ channels characterized as binding sites for nitrendipine during development of nervous, skeletal and cardiac muscle systems in the rat.
    Kazazoglou T; Schmid A; Renaud JF; Lazdunski M
    FEBS Lett; 1983 Nov; 164(1):75-9. PubMed ID: 6317445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyridine sensitive calcium channels in a smooth muscle cell line.
    Kongsamut S; Freedman SB; Miller RJ
    Biochem Biophys Res Commun; 1985 Feb; 127(1):71-9. PubMed ID: 2579654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.